(Total Views: 529)
Posted On: 05/14/2021 10:33:30 AM
Post# of 153897
For those who would like to learn more about Macleods, here are links to their operations in India and internationally. They have multiple business units which are each responsible for several drugs.
https://www.macleodspharma.com/business/
Macleods’ flagship division, which includes almost 120 products, is the company’s largest business unit. With a diverse portfolio; anti-infective, gastrointestinal, blood-related products and anti-hypertensive, the unit reaches out to more than 150,000 doctors in India and caters to almost every speciality, with emphasis on pediatrics, consulting physicians, general practitioners, surgeons, dermatologists and gynaecologists.
https://www.macleodspharma.com/international/
Our international business operations involve varied forms of mutually-beneficial partnerships and collaborations. We also have our own subsidiaries across seven countries – USA, the UK, South Africa, Ukraine, Kazakhstan, Spain and Indonesia. Among many activities, our overseas engagements entail expanding our product portfolio through registrations and by launching novel drugs.
https://www.macleodspharma.com/business/
Macleods’ flagship division, which includes almost 120 products, is the company’s largest business unit. With a diverse portfolio; anti-infective, gastrointestinal, blood-related products and anti-hypertensive, the unit reaches out to more than 150,000 doctors in India and caters to almost every speciality, with emphasis on pediatrics, consulting physicians, general practitioners, surgeons, dermatologists and gynaecologists.
https://www.macleodspharma.com/international/
Our international business operations involve varied forms of mutually-beneficial partnerships and collaborations. We also have our own subsidiaries across seven countries – USA, the UK, South Africa, Ukraine, Kazakhstan, Spain and Indonesia. Among many activities, our overseas engagements entail expanding our product portfolio through registrations and by launching novel drugs.
(5)
(0)
